Enteral Nutrition during Radiotherapy for Oropharyngeal Cancers : Prevalence and Prognostic Factors Based on HPV Status (A GETTEC Study)
Nutritional support during radiotherapy is crucial to tolerating and completing oropharyngeal squamous cell carcinoma (OPSCC) treatment. The impact of HPV status on nutritional support is debated. The objective was to evaluate the rate of Reactive Feeding Tube (RFT) use and determine its prognostic factors during definitive radiotherapy for OPSCC. All OPSCC patients treated from 2009 to 2014 were included in this multicentric retrospective study. The impact of tumor p16 status on the risk of RFT was assessed through multivariate analyses. Among the 543 patients, 103 patients required an RFT (19.0%). The use of RFT differed between centers (5% to 32.4%). In multivariate analysis, only tongue base involvement and concurrent chemotherapy were significantly associated with RFT (OR = 2.18 and 3.7, respectively). Tongue base involvement and concomitant chemotherapy were prognostic factors for RFT. HPV status was not a prognostic factor for enteral nutrition during radiotherapy for OPSCC.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Journal of clinical medicine - 12(2023), 9 vom: 28. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Culié, Dorian [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cancer |
|---|
| Anmerkungen: |
Date Revised 15.05.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/jcm12093169 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356793842 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356793842 | ||
| 003 | DE-627 | ||
| 005 | 20231226071224.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/jcm12093169 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1189.xml |
| 035 | |a (DE-627)NLM356793842 | ||
| 035 | |a (NLM)37176609 | ||
| 035 | |a (PII)3169 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Culié, Dorian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Enteral Nutrition during Radiotherapy for Oropharyngeal Cancers |b Prevalence and Prognostic Factors Based on HPV Status (A GETTEC Study) |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 15.05.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Nutritional support during radiotherapy is crucial to tolerating and completing oropharyngeal squamous cell carcinoma (OPSCC) treatment. The impact of HPV status on nutritional support is debated. The objective was to evaluate the rate of Reactive Feeding Tube (RFT) use and determine its prognostic factors during definitive radiotherapy for OPSCC. All OPSCC patients treated from 2009 to 2014 were included in this multicentric retrospective study. The impact of tumor p16 status on the risk of RFT was assessed through multivariate analyses. Among the 543 patients, 103 patients required an RFT (19.0%). The use of RFT differed between centers (5% to 32.4%). In multivariate analysis, only tongue base involvement and concurrent chemotherapy were significantly associated with RFT (OR = 2.18 and 3.7, respectively). Tongue base involvement and concomitant chemotherapy were prognostic factors for RFT. HPV status was not a prognostic factor for enteral nutrition during radiotherapy for OPSCC | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a cancer | |
| 650 | 4 | |a feeding tube | |
| 650 | 4 | |a human papilloma virus | |
| 650 | 4 | |a nutrition | |
| 650 | 4 | |a oropharynx | |
| 700 | 1 | |a Schiappa, Renaud |e verfasserin |4 aut | |
| 700 | 1 | |a Pace-Loscos, Tanguy |e verfasserin |4 aut | |
| 700 | 1 | |a Guelfucci, Bruno |e verfasserin |4 aut | |
| 700 | 1 | |a Vergez, Sebastien |e verfasserin |4 aut | |
| 700 | 1 | |a Garrel, Renaud |e verfasserin |4 aut | |
| 700 | 1 | |a Fakhry, Nicolas |e verfasserin |4 aut | |
| 700 | 1 | |a Dassonville, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Poissonnet, Gilles |e verfasserin |4 aut | |
| 700 | 1 | |a Lallemant, Benjamin |e verfasserin |4 aut | |
| 700 | 1 | |a Sudaka, Anne |e verfasserin |4 aut | |
| 700 | 1 | |a Saada-Bouzid, Esma |e verfasserin |4 aut | |
| 700 | 1 | |a Benezery, Karen |e verfasserin |4 aut | |
| 700 | 1 | |a Temam, Stephane |e verfasserin |4 aut | |
| 700 | 1 | |a Gorphe, Phillipe |e verfasserin |4 aut | |
| 700 | 1 | |a Chamorey, Emmanuel |e verfasserin |4 aut | |
| 700 | 1 | |a Bozec, Alexandre |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical medicine |d 2012 |g 12(2023), 9 vom: 28. Apr. |w (DE-627)NLM230666310 |x 2077-0383 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2023 |g number:9 |g day:28 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/jcm12093169 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2023 |e 9 |b 28 |c 04 | ||